Enhanced External Counterpulsation on Delayed Onset Muscle Soreness

David Grant U.S. Air Force Medical Center18 enrolled

Overview

This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Muscle Tightness

Interventions

Enhanced External CounterpulsationDEVICE

Enhanced External Counterpulsation

Eligibility

Sex: ALLMin age: 25 YearsMax age: 59 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy active Duty or DoD beneficiaries between 25 and 59 years old Exclusion Criteria: * Not on a physical profile * Not taking any OTC or prescription pain medications or workout supplements

Locations (1)

David Grant USAF Medical Center

Travis Air Force Base, California, United States

Outcomes

Primary Outcomes

Change in delayed onset muscle soreness over time.

Likert pain surveys

Time frame: At 3, 6, 9, 12, 15, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48 Hours

Secondary Outcomes

Pain tolerance

Pain tolerance measured by mmHg pressure required to elicit a delayed-onset muscle pain response.

Time frame: Baseline, 24 hours, 2 days 3 days 4 days 33 days

Bio-markers for muscle inflammation

Bio-markers for muscle inflammation: C-reactive protein, creatine phosphokinase, and white blood cell count.

Time frame: Baseline, 24 hours, 2 days 3 days 4 days 33 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.